Free Trial

Aptamer Group (APTA) Competitors

GBX 0.38 +0.01 (+2.16%)
As of 07:13 AM Eastern

APTA vs. OKYO, SAR, AOR, OPTI, AREC, IMM, POLB, RLM, NSCI, and SNG

Should you be buying Aptamer Group stock or one of its competitors? The main competitors of Aptamer Group include OKYO Pharma (OKYO), Sareum (SAR), AorTech International (AOR), OptiBiotix Health (OPTI), Arecor Therapeutics (AREC), ImmuPharma (IMM), Poolbeg Pharma (POLB), Realm Therapeutics (RLM), NetScientific (NSCI), and Synairgen (SNG). These companies are all part of the "biotechnology" industry.

Aptamer Group vs.

OKYO Pharma (LON:OKYO) and Aptamer Group (LON:APTA) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations, valuation and community ranking.

OKYO Pharma received 7 more outperform votes than Aptamer Group when rated by MarketBeat users.

CompanyUnderperformOutperform
OKYO PharmaOutperform Votes
7
63.64%
Underperform Votes
4
36.36%
Aptamer GroupN/AN/A

OKYO Pharma has higher earnings, but lower revenue than Aptamer Group. Aptamer Group is trading at a lower price-to-earnings ratio than OKYO Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OKYO PharmaN/AN/A-£6.70M-£0.01N/A
Aptamer Group£4.12M1.77-£14.17M-£0.71-0.51

OKYO Pharma has a net margin of 0.00% compared to Aptamer Group's net margin of -343.95%. Aptamer Group's return on equity of -205.63% beat OKYO Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
OKYO PharmaN/A -397.13% -154.72%
Aptamer Group -343.95%-205.63%-44.96%

In the previous week, OKYO Pharma's average media sentiment score of 0.00 equaled Aptamer Group'saverage media sentiment score.

Company Overall Sentiment
OKYO Pharma Neutral
Aptamer Group Neutral

OKYO Pharma has a beta of -0.06, suggesting that its share price is 106% less volatile than the S&P 500. Comparatively, Aptamer Group has a beta of -0.52, suggesting that its share price is 152% less volatile than the S&P 500.

11.7% of Aptamer Group shares are owned by institutional investors. 31.9% of OKYO Pharma shares are owned by insiders. Comparatively, 13.2% of Aptamer Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

OKYO Pharma beats Aptamer Group on 6 of the 11 factors compared between the two stocks.

Get Aptamer Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for APTA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APTA vs. The Competition

MetricAptamer GroupBiotechnology IndustryMedical SectorLON Exchange
Market Cap£7.28M£128.24M£5.33B£2.62B
Dividend YieldN/A3.74%5.21%5.05%
P/E Ratio-0.513.4026.71129.34
Price / Sales1.774,119.82386.08221,585.85
Price / CashN/A13.1938.2528.03
Price / Book1.7133.136.773.79
Net Income-£14.17M-£91.56M£3.23B£5.88B
7 Day Performance3.39%2.88%1.80%0.62%
1 Month Performance40.77%7.98%11.10%22.12%
1 Year Performance-53.38%99.22%17.11%120.95%

Aptamer Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APTA
Aptamer Group
N/AGBX 0.38
+2.2%
N/A-53.4%£7.51M£4.12M-0.5337Gap Up
OKYO
OKYO Pharma
N/AN/AN/AN/A£23.24MN/A-140.007Gap Down
SAR
Sareum
N/AGBX 16.10
-10.6%
N/A-52.6%£20.11MN/A-3.813,211Gap Down
AOR
AorTech International
N/AN/AN/AN/A£19.99M£539,000.00-33.383
OPTI
OptiBiotix Health
N/AGBX 18.11
+0.6%
N/A-2.5%£17.74M£590,009.23-5.731
AREC
Arecor Therapeutics
N/AGBX 41.24
+0.6%
N/A-72.6%£15.57M£6.04M-1.4610News Coverage
Insider Trade
IMM
ImmuPharma
N/AGBX 3.63
+7.6%
N/A+19.3%£15.41M£-71,310.29-6.2713Earnings Report
POLB
Poolbeg Pharma
N/AGBX 2.85
flat
N/A-80.5%£14.65MN/A0.0012Earnings Report
RLM
Realm Therapeutics
N/AN/AN/AN/A£13.41M£501,919.00-0.66N/A
NSCI
NetScientific
N/AN/AN/AN/A£12.81M£1.45M-486.3626
SNG
Synairgen
N/AN/AN/AN/A£9.04MN/A-0.5634Gap Down

Related Companies and Tools


This page (LON:APTA) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners